Enterinex™ Q - Adjunctive Use in Oncology Care

Enterinex™ Q

Adjunctive Use in Oncology Care

Adjusted ratios of key phytochemicals (polyphenols, flavonoids, enzymes) to better align with the nutritional needs of oncology patients. Vitamin C (Amla), Nattokinase, Quercetin (Sophora Japonica), Zinc (Guava Leaves), Bromelain, & Licorice

Immune and Vascular Resilience for Oncology Patients – Certified Organic, Non-GMO

Clinical Positioning
Enterinex™ Q is a USDA Certified Organic, Non-GMO nutritional adjunct for oncology patients, particularly where immune dysregulation, chronic inflammation, and impaired cellular balance are central concerns. It is not a therapy but is designed to complement standard oncologic treatment pathways by supporting the body’s capacity for cellular defense, antioxidant protection, and microcirculatory health.

What Differentiates Enterinex™ Q?

• Builds on the original Enterinex™ formulation, but with adjusted ratios of key phytochemicals (polyphenols, flavonoids, enzymes) to better align with the nutritional needs of oncology patients.
• USDA Organic, Non-GMO, 100% plant-based
• Delivered as a pure botanical extract powder — no pills, no capsules. Taken by scoop, mixed directly into liquid
• Targets domains relevant to cancer supportive care:
• Oxidative stress modulation
• Inflammatory tone regulation
• Immune surveillance support
• Microvascular health

Core Composition

• Amla – antioxidant-rich, supports DNA protection and repair
• Piperine – increases bioavailability of co-administered compounds
• Guava (zinc source) – trace mineral critical for cellular immunity
• Quercetin – flavonoid with evidence for cell cycle and cytokine modulation
• Nattokinase – supports fibrin breakdown and circulation
• Bromelain – enzyme with anti-inflammatory properties and absorption support

Adjunctive Contexts
Enterinex™ Q may be considered as nutritional support in patients with cancers such as:

• Nasopharyngeal carcinoma
• Hodgkin lymphoma
• Burkitt lymphoma
• Gastric carcinoma (defined subset)
• Extranodal NK/T-cell lymphoma
• Post-transplant lymphoproliferative disorder
• Plasmablastic lymphoma
• Primary CNS lymphoma
• Rare smooth muscle tumors in immunocompromised patients

Not Indicated
Currently, there is no supportive evidence for nutritional benefit of Enterinex™ Q in:

• Breast, lung, colorectal, prostate, liver, cervical, thyroid, bladder, or pancreatic cancers

Suggested Use

• Standard: Mix 1 scoop in 8–12 oz water. Take on an empty stomach in the morning
• Alternate: 1 scoop up to 3 times daily, divided and spaced throughout the day, as directed by the treating HCP
• Avoid use with heavy meals. Separate by ~2 hours from medications when possible
• Packaged in 90 servings

Safety & Clinical Considerations

• Monitor patients on anticoagulants or antiplatelet therapy (nattokinase, bromelain)
• Avoid in pregnancy/lactation due to lack of safety data

Enterinex™ Q is a nutritional supplement, not intended to diagnose, treat, cure, or prevent any disease. It is designed solely as adjunctive nutritional support in oncology patients, under the guidance of healthcare professionals.